Bausch Health ehemals VALEANT PHARMA Allergan-Übernahme beflügelt (Seite 22)
eröffnet am 30.04.14 17:10:46 von
neuester Beitrag 10.04.24 21:16:45 von
neuester Beitrag 10.04.24 21:16:45 von
Beiträge: 4.274
ID: 1.193.944
ID: 1.193.944
Aufrufe heute: 0
Gesamt: 390.010
Gesamt: 390.010
Aktive User: 0
ISIN: CA0717341071 · WKN: A2JQ1X · Symbol: BHC
6,8800
USD
-1,01 %
-0,0700 USD
Letzter Kurs 11.05.24 NYSE
Neuigkeiten
09.05.24 · Accesswire |
02.05.24 · Accesswire |
25.04.24 · wO Chartvergleich |
11.04.24 · Accesswire |
11.04.24 · Accesswire |
Werte aus der Branche Pharmaindustrie
Wertpapier | Kurs | Perf. % |
---|---|---|
0,5700 | +55,23 | |
5,4500 | +41,56 | |
141,00 | +41,00 | |
1,1500 | +34,98 | |
1,0000 | +33,33 |
Wertpapier | Kurs | Perf. % |
---|---|---|
1,8700 | -12,62 | |
12,150 | -12,72 | |
35,69 | -13,71 | |
5,2500 | -19,23 | |
0,7300 | -19,34 |
Beitrag zu dieser Diskussion schreiben
Bausch Health First-Quarter 2020 Earnings Presentation 05/07/20
https://ir.bauschhealth.com/events-and-presentations/2020 Bausch Health To Participate at 2020 Bank of America Merrill Lynch Global Healthcare Conference
https://www.bauschhealth.com/news-room/news-releases/news-de…Salix To Highlight New Data Across Its Portfolio Of Products At Digestive Disease Week 2020 Virtual Meeting
https://www.bauschhealth.com/news-room/news-releases/news-de…BRIDGEWATER, N.J., April 30, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology business, Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases, today announced that fourteen new scientific posters featuring research and data spanning Salix's GI portfolio – including rifaximin, plecanatide, methylnaltrexone bromide and PEG-3350, electrolytes and ascorbate for oral solution – will be accessible on Digestive Disease Week®'s (DDW) ePosters and ePapers free, online portal beginning Saturday, May 2, 2020.
Bausch Health Announces 2020 Annual Meeting Of Shareholder Results
https://www.bauschhealth.com/news-room/news-releases/news-de…
FDA Approves Ortho Dermatologics' Labeling For JUBLIA® (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old
https://www.bauschhealth.com/news-room/news-releases/news-de…
https://www.bauschhealth.com/news-room/news-releases/news-de…
Bausch Health Issues Form 8-K For 2020 Annual Meeting Of Shareholders Presentation
https://ir.bauschhealth.com/news-releases/2020/04-28-2020-12…https://ir.bauschhealth.com/~/media/Files/V/Valeant-IR/repor…
09.05.24 · Accesswire · Bausch Health Companies |
02.05.24 · Accesswire · Bausch Health Companies |
25.04.24 · wO Chartvergleich · BAVARIA Industries Group Akt |
11.04.24 · Accesswire · Bausch Health Companies |
11.04.24 · Accesswire · Bausch Health Companies |
03.04.24 · Accesswire · Bausch Health Companies |
02.04.24 · Accesswire · Bausch Health Companies |
06.03.24 · Accesswire · Bausch Health Companies |
05.03.24 · Accesswire · Bausch Health Companies |
04.03.24 · wO Chartvergleich · Myriad Genetics |